文化大學機構典藏 CCUR:Item 987654321/24022
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 47121/50987 (92%)
造訪人次 : 13803854      線上人數 : 301
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CCUR管理 到手機版


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/24022


    Title: Intensity modulated radiotherapy for elderly bladder cancer patients
    Authors: Hsieh, CH (Hsieh, Chen-Hsi)
    Chung, SD (Chung, Shiu-Dong)
    Chan, PH (Chan, Pei-Hui)
    Lai, SK (Lai, Siu-Kai)
    Chang, HC (Chang, Hsiao-Chun)
    Hsiao, CH (Hsiao, Chi-Huang)
    Wu, LJ (Wu, Le-Jung)
    Chong, NS (Chong, Ngot-Swan)
    Chen, YJ (Chen, Yu-Jen)
    Wang, LY (Wang, Li-Ying)
    Hsieh, YP (Hsieh, Yen-Ping)
    Shueng, PW (Shueng, Pei-Wei)
    Contributors: Grad Inst Sport Coaching Sci
    Keywords: Bladder cancer
    Concurrent chemoradiation
    Helical tomotherapy
    Intensity modulated radiation therapy
    Date: 2011-06-16
    Issue Date: 2013-01-17 13:53:13 (UTC+8)
    Abstract: Background: To review our experience and evaluate treatment planning using intensity-modulated radiotherapy (IMRT) and helical tomotherapy (HT) for the treatment of elderly patients with bladder cancer.

    Methods: From November 2006 through November 2009, we enrolled 19 elderly patients with histologically confirmed bladder cancer, 9 in the IMRT and 10 in the HT group. The patients received 64.8 Gy to the bladder with or without concurrent chemotherapy. Conventional 4-field "box" pelvic radiation therapy (2DRT) plans were generated for comparison.

    Results: The median patient age was 80 years old (range, 65-90 years old). The median survival was 21 months (5 to 26 months). The actuarial 2-year overall survival (OS) for the IMRT vs. the HT group was 26.3% vs .37.5%, respectively; the corresponding values for disease-free survival were 58.3% vs. 83.3%, respectively; for locoregional progression-free survival (LRPFS), the values were 87.5% vs. 83.3%, respectively; and for metastases-free survival, the values were 66.7% vs. 60.0%, respectively. The 2-year OS rates for T1, 2 vs. T3, 4 were 66.7% vs. 35.4%, respectively (p = 0.046). The 2-year OS rate was poor for those whose RT completion time greater than 8 weeks when compared with the RT completed within 8 wks (37.9% vs. 0%, p = 0.004).

    Conclusion: IMRT and HT provide good LRPFS with tolerable toxicity for elderly patients with invasive bladder cancer. IMRT and HT dosimetry and organ sparing capability were superior to that of 2DRT, and HT provides better sparing ability than IMRT. The T category and the RT completion time influence OS rate.
    Relation: RADIATION ONCOLOGY Volume: 6 Article Number: 75
    Appears in Collections:[運動教練研究所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML443View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback